The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
Clinical trial NCT04286841 · RECRUITING
Trial details
- NCT number
- NCT04286841
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-01
- Primary completion
- 2022-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.